Clinical Trial Update: 68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk

View source ↗

Summary

This clinical trial evaluates 68Ga-PSMA PET/MRI in conjunction with mpMRI to assess prospective prostate cancer risk. The study is currently recruiting at Chang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA PET/MRI (Gallium-68 PSMA PET/MRI imaging agent)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Prostate Cancer | Status: RECRUITING